A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
NCT05539196
This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
This registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducted at approximately 10 centers worldwide.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Movement Disorders
- Neurology
- Parkinsons Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 30 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- InSightec
- Last updated on ClinicalTrials.gov
- March 20, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- University of Maryland, Baltimore · Baltimore, MD
New York · 1
- Weill Cornell Medicine · New York, NY
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
Texas · 1
- University of Texas Southwestern Medical Center · Dallas, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.